Evidence map›Paper›PMID 28058002›Full record

ArticleUrology annals

The diagnostic yield of fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography in recurrent testicular seminoma.

Athanasios Bantis, Petros Sountoulides, Linda Metaxa, Pavlos Pavlidis, Eleni Aggelonidou, Halil Arif, Athanasios Zisimopoulos

Open access · goldAbstract readCase Reports
In one paragraph

Article in Urology annals. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Spermatocytic tumor: A rare case report.World journal of clinical cases · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Athanasios BantisDepartment of Urology, University Hospital of Alexandroupoli, Alexandroupoli, Greece.
Petros SountoulidesDepartment of Urology, University Hospital of Alexandroupoli, Alexandroupoli, Greece.
Linda MetaxaDepartment of Radiological Sciences, Oncology and Anatomical Pathology, Sapienza University of Rome, Rome, Italy.
Pavlos PavlidisDepartment of Nuclear Medicine, University Hospital of Alexandroupoli, Alexandroupoli, Greece.
Eleni AggelonidouDepartment of Nuclear Medicine, University Hospital of Alexandroupoli, Alexandroupoli, Greece.
Halil ArifDepartment of Urology, University Hospital of Alexandroupoli, Alexandroupoli, Greece.
Athanasios ZisimopoulosDepartment of Nuclear Medicine, University Hospital of Alexandroupoli, Alexandroupoli, Greece.
University Hospital of Alexandroupolis · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of positron emission tomography-computed tomography (PET-CT) scan imaging is undoubtedly a significant evolution in oncological urology, although at present of limited use in every day urology practice. The aim of this study is to highlight the indication and diagnostic accuracy of fluorine-18 fluorodeoxyglucose PET/CT in the staging of a patient with metachronous bilateral testicular seminoma, elevated tumor markers, and equivocal conventional imaging findings.

Indexed as

Bilateral seminomachemotherapyfluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography scantestis tumors

Identifiers

PMID28058002
PMCPMC5100163
OpenAlexW2530946179

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.